Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.29M
39.85K shares
What this filing means
GHEUENS SARAH plans to sell 39.85K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $1.29M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/26/2026ACC: 0001950047-26-010399
Officer· Chief Medical Officer
Since Sep 2021
39.85K
Shares to sell
$1.29M
Approx. market value
7.87K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/26/2026
7.87KTotal acquired7.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2026 | Stock Option Exercise Cash | 7.87K | — |
| Total | 7.87K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
500.00
Market value
$18.8K
10/22/2026
—Completed
Units to sell
1.49K
Market value
$55.9K
10/21/2026
—Completed
Units to sell
30K
Market value
$914.3K
8/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.87K
Market value
$296.5K
10/26/2026
Total
Units
39.85K
Value
$1.29M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/22/2026 | 500.00 | $18.8K | — | Completed |
10/21/2026 | 1.49K | $55.9K | — | Completed |
8/4/2026 | 30K | $914.3K | — | Completed |
| Planned — Approximate Date | ||||
10/26/2026 | 7.87K | $296.5K | NASDAQ | Planned |
| Total | 39.85K | $1.29M | ||